Ascend Capital’s Nutrien NTR Stock Holding History

Ascend Capital’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-206,133	Closed	-$9.74M	–	215
2018 Q1	$9.74M	Buy	+206,133	New	+$10.3M	0.4%	83

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Ascend Capital's NTR Position: Q2 2018 in Review

Ascend Capital sold out of Nutrien (NTR) in Q2 2018, closing a stake of 206,133 shares — an estimated $9.74M sold.

Ascend Capital first reported a position in NTR in Q1 2018 and held it in 1 quarter. The position peaked at $9.74M in Q1 2018. 562 funds tracked by Wall St. Rank hold NTR as of Q2 2018.

Ascend Capital reported no remaining Nutrien position as of Q2 2018 after selling out during the quarter.
Ascend Capital sold 206,133 Nutrien shares in Q2 2018, an estimated $9.74M.
Ascend Capital first reported a position in Nutrien in Q1 2018 and held it in 1 quarter.
Ascend Capital's Nutrien position peaked at $9.74M in Q1 2018.
562 funds tracked by Wall St. Rank held Nutrien as of Q2 2018.

Based on Ascend Capital's 13F filing for Q2 2018, filed 13 Aug 2018.